{"lc": {"ivermectin-can-kill-covid-19-within-48-hours-monash-university-study-finds": {"story_link": "https://www.thepharmaletter.com/article/ivermectin-can-kill-covid-19-within-48-hours-monash-university-study-finds", "user_code": "GOLD_17", "age_group": "21_30", "agreed": true, "close_date_time": "2021-10-23 13:24:18", "close_timestamp": 1637673858518, "created": "23/11/2021 13:24:19", "department": "Computing", "disability": false, "ease": 4, "environment": "production", "experiment_date_datepicker": "2021-11-23", "gender": "female", "id": "7a895181-eff6-4421-bef1-7aaf82e0bb98", "open_date_time": "2021-10-23 13:17:22", "open_timestamp": 1637673442280, "story_date": "2020-04-21 00:00:00", "story_source": "tpl", "story_title": "Ivermectin can kill COVID-19 within 48 hours', Monash University study finds", "summary": "An anti-parasitic drug already available around the world kills the virus within 48 hours, and scientists in Monash BDI are figuring out whether it is effective in humans. Moreover, a study is also underway to see if Ivermectin can fight the coronavirus.", "task_condition": "text", "task_key": "ivermectin-can-kill-covid-19-within-48-hours-monash-university-study-finds", "task_level": "post_graduate_ma_msc", "time_taken_in_seconds": 416238, "what": "An anti-parasitic drug already available around the world kills the virus within 48 hours, and scientists in Monash BDI are figuring out whether it is effective in humans.", "when_happened": "few_years_ago", "where_location": "Australia", "who": "an anti-parasitic drug named Ivermectin", "why": "If we had a compound that was already available around the world then that might help people sooner"}, "challenges-expected-for-novavax-covid-19-vaccine-in-usa": {"story_link": "https://www.thepharmaletter.com/article/challenges-expected-for-novavax-covid-19-vaccine-in-usa", "user_code": "GOLD_17", "age_group": "21_30", "agreed": true, "close_date_time": "2021-10-23 13:6:7", "close_timestamp": 1637672767493, "created": "23/11/2021 13:06:09", "department": "Computing", "disability": false, "ease": 3, "environment": "production", "experiment_date_datepicker": "2021-11-23", "gender": "female", "id": "a254337d-b3dc-451c-bfbb-e2aa9e14dae2", "open_date_time": "2021-10-23 12:57:12", "open_timestamp": 1637672232623, "story_date": "2021-06-23 00:00:00", "story_source": "tpl", "story_title": "Challenges expected for Novavax' COVID-19 vaccine in USA", "summary": "Novavax in USA has developed a vaccine by studying global data of patients. However, the extent to which the vaccine is effective is challenged by the emergence of strains of the coronavirus.", "task_condition": "viz", "task_key": "challenges-expected-for-novavax-covid-19-vaccine-in-usa", "task_level": "post_graduate_ma_msc", "time_taken_in_seconds": 534870, "what": "Novavax' COVID-19 vaccine's challenges", "when_happened": "few_month_ago", "where_location": "the United States", "who": "Novavax' COVID-19 vaccine", "why": "It involves many countries and people, and concerns the ability to fight the coronavirus."}, "australian-gps-urged-to-prescribe-ivermectin-triple-therapy-to-fight-covid-19": {"story_link": "https://www.thepharmaletter.com/article/australian-gps-urged-to-prescribe-ivermectin-triple-therapy-to-fight-covid-19", "user_code": "GOLD_17", "age_group": "21_30", "agreed": true, "close_date_time": "2021-10-23 12:57:4", "close_timestamp": 1637672224081, "created": "23/11/2021 12:57:05", "department": "Computing", "disability": false, "ease": 4, "environment": "production", "experiment_date_datepicker": "2021-11-23", "gender": "female", "id": "5c512507-5bcb-431d-9952-0ff778f200d3", "open_date_time": "2021-10-23 12:46:43", "open_timestamp": 1637671603594, "story_date": "2020-08-20 00:00:00", "story_source": "tpl", "story_title": "Australian GPs urged to prescribe ivermectin triple therapy to fight COVID-19", "summary": "Following the outbreak of the Covid-19, Australian GPs invested in researching a treatment option using doxycycline et al. to fight it. People are immunized with these medications and there is a marked improvement in the patients' condition. The government encourages this research and investment.", "task_condition": "viz", "task_key": "australian-gps-urged-to-prescribe-ivermectin-triple-therapy-to-fight-covid-19", "task_level": "post_graduate_ma_msc", "time_taken_in_seconds": 620487, "what": "urge therapy to fight COVID-19", "when_happened": "few_years_ago", "where_location": "Australia", "who": "Australian GPs", "why": "Covid-19 is a world level incident."}, "japan-is-first-country-to-approve-covid-19-cocktail-ronapreve": {"story_link": "https://www.thepharmaletter.com/article/japan-is-first-country-to-approve-covid-19-cocktail-ronapreve", "user_code": "GOLD_17", "age_group": "21_30", "agreed": true, "close_date_time": "2021-10-23 13:17:15", "close_timestamp": 1637673435508, "created": "23/11/2021 13:17:17", "department": "Computing", "disability": false, "ease": 3, "environment": "production", "experiment_date_datepicker": "2021-11-23", "gender": "female", "id": "2ea946f2-6002-4e55-af0c-0efd5aeba510", "open_date_time": "2021-10-23 13:6:13", "open_timestamp": 1637672773679, "story_date": "2020-07-21 00:00:00", "story_source": "tpl", "story_title": "Japan is first country to approve COVID-19 cocktail Ronapreve", "summary": "Chugai Pharmaceutical has developed Ronapreve, which is useful against the coronavirus, and makes Japan the first country to formally authorize this drug. Besides, this antibody combination has been authorized for emergency use worldwide.", "task_condition": "text", "task_key": "japan-is-first-country-to-approve-covid-19-cocktail-ronapreve", "task_level": "post_graduate_ma_msc", "time_taken_in_seconds": 661829, "what": "Chugai Pharmaceutical has developed Ronapreve, which is useful against the coronavirus and is about to expand use.", "when_happened": "few_years_ago", "where_location": "Japan", "who": "Ronapreve", "why": "Japan is the first country to formally authorize the drug and it is useful."}}, "tb": {"pfizer": {"story_term": "pfizer", "user_code": "GOLD_17", "age_group": "21_30", "agreed": true, "close_date_time": "2021-10-23 13:55:41", "close_timestamp": 1637675741473, "created": "23/11/2021 13:55:43", "department": "Computing", "disability": false, "ease": 2, "environment": "production", "experiment_date_datepicker": "2021-11-23", "gender": "female", "id": "82b03a88-2572-427c-bd28-b466909fa0c7", "open_date_time": "2021-10-23 13:40:6", "open_timestamp": 1637674806379, "summary": "Pharmaceutical companies, especially Pfizer, in several countries have made numerous achievements in the vaccine research against the coronavirus. For example, Pfizer, BioNTech and AstraZeneca are effective against the so-called Indian variant. At the same time, the US has expanded Pfizer's emergency use authorization and relaxed age restrictions. The Japan-based Sosei Group has reached a new level of cooperation with Pfizer. It is worth mentioning that the US Food and Drug Administration (FDA) has approved Myfembree, which is also developed with the participation of Pfizer, the first once-daily treatment for the management of heavy menstrual bleeding associated with uterine fibroids in premenopausal women.\r\n\r\n", "task_condition": "text", "task_key": "pfizer", "task_level": "post_graduate_ma_msc", "time_taken_in_seconds": 935094}, "astrazeneca": {"story_term": "astrazeneca", "user_code": "GOLD_17", "age_group": "21_30", "agreed": true, "close_date_time": "2021-10-23 13:39:59", "close_timestamp": 1637674799960, "created": "23/11/2021 13:40:01", "department": "Computing", "disability": false, "ease": 2, "environment": "production", "experiment_date_datepicker": "2021-11-23", "gender": "female", "id": "6fe1555b-9b08-4ca6-b0a0-ab21e077efaa", "open_date_time": "2021-10-23 13:24:24", "open_timestamp": 1637673864898, "summary": "AstraZeneca presents the results and reactions to vaccination in places such as Eurasia, where trust in vaccines has increased and the wider rollout of vaccines has facilitated people to work and live normally. AstraZeneca are effective against the so-called Indian variant. However, a long-awaited USA-based Phase III trial of Covid-19 Vaccine AstraZeneca has proved successful, paving the way for its use in the country. Moreover, there are risks associated with vaccination such as unusual blood slots.", "task_condition": "viz", "task_key": "astrazeneca", "task_level": "post_graduate_ma_msc", "time_taken_in_seconds": 935062}}}